JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: RO1138452 is a novel, potent and selective antagonist of the IP (prostacyclin) receptor. RO1138452 displays high affinity for IP receptors. In human platelets, pKi is 9.3+/-0.1; in a recombinant IP receptor system, pKi is 8.7+/-0.06. RO1138452 possesses analgesic and anti-inflammatory potential. RO1138452 (1-10?mg/kg, i.v.) significantly reduces acetic acid-induced abdominal constrictions. RO1138452 (3-100?mg/kg, p.o.) significantly reduces carrageenan-induced mechanical hyperalgesia and edema formation. One?hour after administration of RO1138452 (5?mg/kg, i.v.) to rats, the total plasma concentration is 0.189 ?ug/mL, whereas the free plasma concentrations is calculated to be 0.009?ug/mL (28 nM).
References: Br J Pharmacol. 2006 Feb; 147(3):335-45.; J Pharmacol Exp Ther. 2008 Feb; 324(2):815-26.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!